GLOBEALERT
BUSINESS● LOWAug 13 · Aug 13, 2026, 8:17 AM

Outlook Therapeutics slides after pricing $55M securities offering

Seeking Alpha Tech

Outlook Therapeutics' stock has declined following the pricing of its $55 million securities offering. This indicates a negative market reaction to the company's financial maneuver.

GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.

More in Business